7:04 AM ET
8-K
Loan & Debt
Altimmune $10M Debt Financing with Hercules Capital, Inc.
Altimmune, Inc. has drawn down $10.0 million (Tranche Three) from its existing $125.0 million Loan and Security Agreement with Hercules Capital, Inc. following the achievement of specific clinical and financial milestones. The draw-down extends the interest-only period and amortization date to June 1, 2028, and requires the company to maintain a minimum cash balance equal to 60% of the outstanding principal.
- Value
- $10M
- Counterparty
- Hercules Capital, Inc.
- Term
- through June 1, 2028